US · AVNS
Avanos Medical, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Alpharetta, GA 30004
- Website
- avanos.com
Price · as of 2025-12-31
$24.66
Market cap 654.51M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $27.78 | +12.65% |
| Intrinsic Value(DCF) | $5.59 | -77.33% |
| Graham-Dodd Method(GD) | $0.94 | -96.17% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | $30.57 | $25.75 | |||
| 2014 | $46.61 | $131.13 | $3.17 | $0.00 | $4.51 |
| 2015 | $27.72 | $84.22 | $0.21 | $0.00 | $0.00 |
| 2016 | $39.44 | $44.95 | $2.21 | $5.85 | $0.00 |
| 2017 | $48.33 | $52.93 | $0.00 | $18.21 | $26.90 |
| 2018 | $43.08 | $89.16 | $1.71 | $16.97 | $17.59 |
| 2019 | $32.86 | $40.93 | $0.00 | $4.93 | $0.00 |
| 2020 | $48.23 | $50.93 | $0.00 | $6.65 | $0.00 |
| 2021 | $31.71 | $1,049.41 | $0.00 | $10.40 | $1.59 |
| 2022 | $27.22 | $34.19 | $0.00 | $16.70 | $0.31 |
| 2023 | $19.89 | $40.09 | $0.00 | $2.81 | $0.00 |
| 2024 | $15.24 | $13.43 | $0.00 | $0.00 | $0.00 |
| 2025 | $13.98 | $27.78 | $0.00 | $0.94 | $0.00 |
AI valuation
Our deep-learning model estimates Avanos Medical, Inc.'s (AVNS) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $27.78
- Current price
- $24.66
- AI upside
- +12.65%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$5.59
-77.33% upside
Graham-Dodd
$0.94
-96.17% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| AVNS | Avanos Medical, Inc. | $24.66 | 654.51M | +13% | -77% | -96% | — | -8.90 | 0.83 | 0.93 | -20.72 | — | 2.44 | 49.77% | -8.78% | -9.68% | -9.07% | -7.21% | -6.54% | 0.17 | -15.40 | 2.15 | 1.17 | -1.18 | -8288.00% | 195.00% | -4801.00% | 6.64% | 0.45 | 5.05% | 0.00% | 0.00% | 3.58% | -11.17 | 15.96 | 0.98 | 0.98 |
| BCYC | Bicycle Therapeutics plc | $5.73 | 397.02M | +373% | +110% | — | — | -3.52 | 0.75 | 16.88 | 1.67 | — | 0.75 | -390.34% | -594.96% | -479.18% | -29.04% | 217.72% | -21.78% | 0.01 | -121.31 | 13.81 | 13.61 | 5.28 | -4291.00% | 3076.00% | 16112.00% | -27.87% | -2.45 | 177.02% | 0.00% | 0.00% | 65.25% | 1.31 | 1.65 | -7.78 | 1.58 |
| BVS | Bioventus Inc. | $8.78 | 588.05M | +221% | -58% | — | — | -1890.78 | 4.06 | 1.05 | 22.83 | — | -2.28 | 67.72% | -2.09% | -5.85% | -0.20% | -2.20% | -0.04% | 2.27 | -0.31 | 1.31 | 0.80 | 7.50 | -7912.00% | 1189.00% | 37343.00% | 6.28% | 0.18 | 7.76% | 0.00% | 0.00% | 10.62% | -74.74 | 23.69 | 1.56 | 0.82 |
| CBLL | CeriBell, Inc. | $18.67 | 692.58M | +73% | +350% | — | — | -12.42 | 3.80 | 7.45 | -10.25 | — | 3.82 | 87.89% | -65.57% | -59.97% | -29.21% | -202.59% | -25.36% | 0.14 | -30.90 | 9.73 | 9.08 | 0.33 | -5693.00% | 3609.00% | 1427.00% | -6.27% | -2.13 | -144.22% | 0.00% | 0.00% | 0.00% | -9.04 | -12.70 | 5.93 | 17.63 |
| CLPT | ClearPoint Neuro, Inc. | $12.57 | 373.94M | +192% | -56% | — | — | -18.68 | 13.91 | 11.25 | -18.87 | — | 14.18 | 60.92% | -62.91% | -60.25% | -81.24% | -189.62% | -46.22% | 0.14 | — | 3.22 | 2.40 | 0.93 | -2222.00% | 3104.00% | -3610.00% | -2.61% | -0.86 | -88.59% | 0.00% | 0.00% | 2.08% | -17.05 | -36.50 | 10.73 | 8.37 |
| CTKB | Cytek Biosciences, Inc. | $4.48 | 572.83M | +597% | -46% | — | — | -8.51 | 1.66 | 2.81 | -18.31 | -0.83 | 1.84 | 51.84% | -20.04% | -33.02% | -18.05% | -35.25% | -13.85% | 0.04 | -85.20 | 5.04 | 4.16 | 4.42 | 102798.00% | 52.00% | -14013.00% | -1.55% | -0.06 | -7.65% | 0.00% | 0.00% | 0.00% | -7.88 | -36.31 | 1.58 | 3.49 |
| CYH | Community Health Systems,… | $3.46 | 479.28M | +184% | -61% | — | +667% | 0.67 | -0.33 | 0.04 | 5.83 | — | -0.09 | 8.67% | -79.42% | 4.08% | -40.87% | -92.22% | 4.96% | -8.31 | -11.40 | 1.46 | 1.06 | 5.60 | -19667.00% | -118.00% | 7333.00% | 45.79% | 0.25 | 2.07% | 0.00% | 0.00% | 164.44% | -1.19 | 56.61 | 0.94 | -1.80 |
| FDMT | 4D Molecular Therapeutics… | $9.66 | 492.74M | +142% | -52% | — | +2,596% | -1.36 | 0.43 | 5933.81 | 1.00 | -8.80 | 0.43 | 100.00% | -507678.38% | -434778.38% | -39.31% | -259.80% | -35.74% | 0.05 | — | 14.92 | 14.58 | 0.69 | 1550.00% | -9982.00% | 7613.00% | -63.02% | -4.62 | -191.38% | 0.00% | 0.00% | 0.00% | 0.96 | 1.31 | -4884.32 | 0.97 |
| LAB | Standard BioTools Inc. | $1.13 | 434.56M | +2,535% | -50% | -88% | +606% | -5.60 | 0.99 | 4.92 | -2.77 | — | 0.99 | 49.86% | -109.34% | -87.77% | -16.72% | -23.68% | -12.69% | 0.07 | -3588.65 | 4.19 | 1.86 | 0.92 | -6154.00% | -5108.00% | -4555.00% | -19.69% | -0.69 | -34.48% | 0.00% | 0.00% | 0.00% | -2.82 | -3.18 | 3.08 | 2.09 |
| PACB | Pacific Biosciences of Ca… | $1.68 | 507.2M | +1,311% | -61% | — | — | -0.89 | 90.85 | 3.04 | -28.24 | -1.27 | -1.48 | 31.67% | -348.46% | -341.47% | -213.45% | -87.50% | -53.45% | 141.98 | -80.18 | 6.89 | 5.79 | -14.03 | 7009.00% | 389.00% | -4633.00% | -23.44% | -2.04 | -17.88% | 0.00% | 0.00% | 28.22% | -1.73 | -8.48 | 6.04 | -1.28 |
| VREX | Varex Imaging Corporation | $13.17 | 552.08M | +77% | -64% | — | — | -6.94 | 1.03 | 0.57 | 209.03 | -15.31 | 1.86 | 34.39% | -3.29% | -8.32% | -13.87% | -3.65% | -6.01% | 0.85 | -0.78 | 3.43 | 1.67 | 73.40 | 4530.00% | 414.00% | -784.00% | 3.88% | 0.22 | 2.47% | 0.00% | 0.00% | 9.24% | -26.32 | 38.91 | 0.87 | 1.63 |
About Avanos Medical, Inc.
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
- CEO
- David C. Pacitti
- Employees
- 2.23K
- Beta
- 1.09
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($5.59 ÷ $24.66) − 1 = -77.33% (DCF, example).